![Joan Connolly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joan Connolly
Hoofd Techniek/Wetenschap/O&O bij
ENGENE THERAPEUTICS INC.
Vermogen: - $ op 30-06-2026
Profiel
Joan Connolly is currently Chief Technology Officer at enGene Therapeutics, Inc. since 2024.
Formerly, Ms. Connolly was Chief Technology Officer at Albireo Pharma, Inc. from 2021 to 2023 and Senior Vice President-Technical Operations at Stemline Therapeutics, Inc. Education includes an undergraduate degree from Queen's University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-06-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van Joan Connolly
| Bedrijven | Functie | Begin |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 21-10-2024 |
Eerdere bekende functies van Joan Connolly
| Bedrijven | Functie | Einde |
|---|---|---|
| ALBIREO PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| STEMLINE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Joan Connolly
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Kies MarketScreener 
